Your browser doesn't support javascript.
loading
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
Fuster, José J; MacLauchlan, Susan; Zuriaga, María A; Polackal, Maya N; Ostriker, Allison C; Chakraborty, Raja; Wu, Chia-Ling; Sano, Soichi; Muralidharan, Sujatha; Rius, Cristina; Vuong, Jacqueline; Jacob, Sophia; Muralidhar, Varsha; Robertson, Avril A B; Cooper, Matthew A; Andrés, Vicente; Hirschi, Karen K; Martin, Kathleen A; Walsh, Kenneth.
Afiliación
  • Fuster JJ; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA. jjfuster@bu.edu kxwalsh@bu.edu.
  • MacLauchlan S; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Zuriaga MA; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Polackal MN; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Ostriker AC; Yale Cardiovascular Research Center, Vascular Biology and Therapeutics Program, and Departments of Medicine and Pharmacology, Yale University School of Medicine, New Haven, CT 06511, USA.
  • Chakraborty R; Yale Cardiovascular Research Center, Vascular Biology and Therapeutics Program, and Departments of Medicine and Pharmacology, Yale University School of Medicine, New Haven, CT 06511, USA.
  • Wu CL; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Sano S; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Muralidharan S; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Rius C; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and CIBER de Enfermedades Cardiovasculares, Madrid, Spain.
  • Vuong J; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Jacob S; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Muralidhar V; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
  • Robertson AA; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Cooper MA; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Andrés V; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and CIBER de Enfermedades Cardiovasculares, Madrid, Spain.
  • Hirschi KK; Yale Cardiovascular Research Center and Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT 06511, USA.
  • Martin KA; Yale Cardiovascular Research Center, Vascular Biology and Therapeutics Program, and Departments of Medicine and Pharmacology, Yale University School of Medicine, New Haven, CT 06511, USA.
  • Walsh K; Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA. jjfuster@bu.edu kxwalsh@bu.edu.
Science ; 355(6327): 842-847, 2017 02 24.
Article en En | MEDLINE | ID: mdl-28104796

Texto completo: 1 Colección: 01-internacional Asunto principal: Células Madre Hematopoyéticas / Proteínas Proto-Oncogénicas / Proteínas de Unión al ADN / Aterosclerosis / Hematopoyesis Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Science Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Células Madre Hematopoyéticas / Proteínas Proto-Oncogénicas / Proteínas de Unión al ADN / Aterosclerosis / Hematopoyesis Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Science Año: 2017 Tipo del documento: Article